Test Code CARTA Carbamazepine, Total, Serum
Reporting Name
Carbamazepine, Tot, SUseful For
Monitoring therapy
Determining compliance
Assessing toxicity
Method Name
Homogeneous Microparticle Agglutination Immunoassay
Performing Laboratory

Specimen Type
Serum RedOrdering Guidance
This test measures carbamazepine only. For assessment of its active metabolite, carbamazepine-10,11-epoxide, which is the predominant form in children, order CARBG / Carbamazepine-10,11-Epoxide, Serum)
Specimen Required
Collection Container/Tube: Red top
Specimen Volume: 0.5 mL
Submission Container/Tube: Plastic vial
Collection Instructions: Centrifuge and aliquot serum into a plastic vial within 2 hours of collection.
Reject Due To
Gross hemolysis | Reject |
Specimen Minimum Volume
0.25 mL
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
Serum Red | Refrigerated (preferred) | 7 days |
Frozen | 28 days | |
Ambient | 48 hours |
Reference Values
Therapeutic: 4.0-12.0 mcg/mL
Critical value: ≥15.0 mcg/mL
Day(s) Performed
Monday through Sunday
Test Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
80156
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
CARTA | Carbamazepine, Tot, S | 3432-2 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
CARTA | Carbamazepine, Tot, S | 3432-2 |
Report Available
Same day/1 dayForms
If not ordering electronically, complete, print, and send 1 of the following forms with the specimen:
-Neurology Specialty Testing Client Test Request (T732)
-Therapeutics Test Request (T831)